Cardiac Prosthetic Devices Market Statistics
The global cardiac prosthetic devices market is likely to grow at a CAGR of 9.3% during 2018 to 2026.
The growing cardiac complications such as atrial fibrillation, strokes, and cardiac valve disfunction are the key factors driving the cardiac prosthetic devices market during the forecast period.
Bionic Heart to Bolster the Demand for Cardiac Prosthetic Devices
With rising geriatric population, the cardiac disorders are on the rise and that makes the demand for cardiac devices to go up. Engineers and researchers have developed a more realistic heart called Bionic heart that removes the problems of conventional prosthetic devices. The conventional cardiac prosthetic devices had issues such as leakage around the valve, however the bionic hearts are coming across as a boon in the cardiac surgery area. This device acts as a real biological heart whose real heart muscles has been replaced with artificial robotic matrix. The researchers envisage that this new design is also known as ‘biorobotic hybrid heart’ can help in reducing the cost of the device development of the cardiac surgeries. These immense benefits are expected to drive the market for cardiac prosthetic devices market.
Transcatheter Heart Valves to Drive the Cardiac Prosthetic Devices Market
The Mitral regurgitation is a common disease in which the left side of the valve in heart chamber does not close and is a most common condition among elderly population. According to American College of Cardiology, approximately 4 million patients suffer from mitral valve in sufficiency, which further is an indicator or factor that could drive the cardiac prosthetic devices market during the forecast years. Further, these heart valve replacement devices help patients with severe cardiovascular devices and prevents calcification, infection, etc, thus expected to boost the demand for cardiac prosthetic devices market.
Moreover, robotic surgeries with tools controlled by robots and the surgery performed by a skilled surgeon will be minimally invasive and it is gaining importance in the field of cardiac surgery which further could expand the global cardiac prosthetic devices market in the coming years. This surgery is also known as da vinci procedure as it is the name of the manufacturing company that makes this robot which is used in the surgery. Robotic surgeries are performed in coronary artery bypass, valve surgeries, etc.
However, the high cost of cardiac prosthetics surgeries is expected to hamper the market in the coming years.
Despite that, rising prevalence of degenerative cardiac diseases among the geriatric population might add to the growth opportunities over the forecast years.
Durability Factor to Strengthen Mechanical Valve Segment
Based on the product types, the global cardiac prosthetics market is segmented into mechanical valves, tissue valves, and transcatheter valves. However, during the forecast period, the mechanical valve segment is projected to hold a largest share in the market. Mechanical valves offer range of benefits such as they don’t have structural degeneration, which makes them durable. They also offer lower profile which makes the implants easier for the patients with smaller hearts. They also reduce the risk of developing thrombosis by offering anticoagulant properties, therefore resulting the growth of the mechanical valve segment boosting the market for cardiac prosthetic devices market in the coming years. Mechanical valve happens to be the largest revenue generating prosthetic device, which further is expected to continue over the years.
Transcatheter segment is projected to grow significantly during the forecast years because it is a minimally invasive procedure, it helps in restoring blood flow, and also minimizes shortness of breath, and fatigue.
Regional Analysis- North America to Maintain its Market Supremacy
North America happens to be the hub of technology and advanced health infrastructure which allows it maintain the dominance in the global cardiac prosthetic market. Further, every year around 60,000 patients undergo heart valve replacement surgery which makes establishes the market in the region. Also, lifestyle diseases leasing to cardiovascular diseases are on the rise among the young children, which enhances the growth of the market in the region.
Asia Pacific is projected to emerge as a strong market in the coming years. Primarily in Asian countries, Transcatheter aortic valve replacement surgeries are performed more, the expandable balloon from Edward Sapiens is the most prosthesis used in TAVR surgeries in Asia Pacific. Medtronic’s self-expandable prosthesis takes second place in TAVR surgeries in Asia.
Competitive Landscape
The competition in the global cardiac prosthetics market is highly competitive due to the stalwarts of medical devices manufacturers grabbing the larger share in the world-wide arena. These players are fixing their gaze on product innovation, amplifying research and development, mergers and acquisitions.
Recent critical Development include
In April 2022 Boston Scientific Corporation received FDA approval for its EMBOLD™ Fibered Detachable Coil, which is designed to reduce the blood flow in peripheral vasculature. It also reduced the surgery time.
In Feb 2022, Medtronic received FDA’s expanded approval cardiac cryoablation catheters for common heart rhythm condition in pediatric treatment. This treatment is going to be the first line treatment foe pediatric patients with Atrioventricular Nodal Re-entrant Tachycardia (AVNRT) disease.
In Jan 2022, Abbott received the approval from FDA for a new cardiac mapping system to enhance the treating ways of abnormal heart rhythms. Currently the mapping platform is available across the USA and Europe.
The global players in the cardiac prosthetic devices market include-
- Siemens Healthcare GmbH
- Boston Scientific Corporation
- Jude Medica
- Medtronic, Inc.
- Boston Scientific Corporation
- Abbott Vascular
- Sorin Group
Product Outlook (Revenue, USD Million)
- Heart valves
- Mechanical valve
- Tissue valve
- Stented tissue valve
- Stentless tissue valve
- Transcatheter valve
- Pacemakers
- Implantable pacemakers
- Single-Chamber Battery Pacemaker
- Dual-Chamber Battery Pacemaker
- Triple-Chamber Battery Pacemaker
- External pacemaker
Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia Pacific
- China
- India
- Japan
- South Korea
Latin America
- Brazil
- Mexico
Middle East & Africa (MEA
Frequently Asked Questions
At what rate of Cardiac Prosthetic Devices Market is likely to grow?
The global cardiac prosthetic devices market is likely to grow at a CAGR of 9.3% between 2018 to 2026
Which region would have largest share in Cardiac Prosthetic Devices Market?
North America is projected to hold a largest share in the market.
Who are the major players in Cardiac Prosthetic Devices Market?
Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, Abbott Laboratories, LivaNova PLC
What is the forecast period of the global Cardiac Prosthetic Devices Market?
The study period is between 2018 to 2026
Table Of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Product Outlook
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Outlook, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Outlook, 2022-2032
5.3.1. Heart valves
5.3.2. Mechanical valve
5.3.3. Tissue valve
5.3.3.1. Stented tissue valve
5.3.3.2. Stentless tissue valve
5.3.4. Transcatheter valve
5.3.5. Pacemakers
5.3.6. Implantable pacemakers
5.3.6.1. Single-Chamber Battery Pacemaker
5.3.6.2. Dual-Chamber Battery Pacemaker
5.3.6.3. Triple-Chamber Battery Pacemaker
5.3.6.4. External pacemaker
5.4. Y-o-Y Growth Trend Analysis By Product Outlook, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Outlook, 2022-2032
6. Global Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
6.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. East Asia
6.3.5. South Asia
6.3.6. Oceania
6.3.7. MEA
6.4. Market Attractiveness Analysis By Region
7. North America Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
7.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Product Outlook
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Product Outlook
7.4. Key Takeaways
8. Latin America Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Argentina
8.2.1.4. Chile
8.2.1.5. Peru
8.2.1.6. Rest of Latin America
8.2.2. By Product Outlook
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Outlook
8.4. Key Takeaways
9. Europe Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. Italy
9.2.1.3. France
9.2.1.4. U.K.
9.2.1.5. Spain
9.2.1.6. Russia
9.2.1.7. BENELUX
9.2.1.8. Rest of Europe
9.2.2. By Product Outlook
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Outlook
9.4. Key Takeaways
10. East Asia Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. South Korea
10.2.2. By Product Outlook
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Outlook
10.4. Key Takeaways
11. South Asia Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Thailand
11.2.1.3. Malaysia
11.2.1.4. Indonesia
11.2.1.5. Rest of South Asia
11.2.2. By Product Outlook
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Outlook
11.4. Key Takeaways
12. Oceania Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Australia
12.2.1.2. New Zealand
12.2.2. By Product Outlook
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Outlook
12.4. Key Takeaways
13. MEA Cardiac Prosthetic Devices Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC
13.2.1.2. Rest of MEA
13.2.2. By Product Outlook
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Outlook
13.4. Key Takeaways
14. Key Countries Cardiac Prosthetic Devices Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Outlook
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Outlook
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Outlook
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Outlook
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Outlook
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Outlook
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Siemens Healthcare GmbH
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Boston Scientific Corporation
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. St. Jude Medica
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Medtronic, Inc.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Boston Scientific Corporation
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Abbott Vascular
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Sorin Group
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Request Free Sample
